Mayuko Kondo
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Early steroid initiation may improve outcomes in immune checkpoint inhibitor-related cholangitis: a multicenter cohort study.
Journal: Immunological medicine
Published: July 06, 2026
Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia.
Journal: Hepatology international
Published: September 06, 2025
Granulocyte-monocyte/macrophage apheresis for steroid-nonresponsive or steroid-intolerant severe alcohol-associated hepatitis: A pilot study.
Journal: Hepatology communications
Published: October 18, 2023
Effectiveness of direct acting antiviral agents for hepatitis C virus related recurrent hepatocellular carcinoma patients who had multiple courses of recurrence.
Journal: Journal of viral hepatitis
Published: November 30, 2020
Correction to: Long‑term survival after palliative argon plasma coagulation for intraductal papillary mucinous neoplasm of the bile duct.
Journal: Clinical journal of gastroenterology
Published: September 19, 2020
Risk factors of poor prognosis and impairment of activities of daily living in patients with hemorrhagic gastroduodenal ulcers.
Journal: BMC gastroenterology
Published: March 28, 2020
Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study.
Journal: Drugs - real world outcomes
Published: February 13, 2020
Long-term survival after palliative argon plasma coagulation for intraductal papillary mucinous neoplasm of the bile duct.
Journal: Clinical journal of gastroenterology
Published: December 15, 2019
Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report.
Journal: Journal of medical case reports
Published: November 26, 2019
Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients.
Journal: Journal of gastroenterology
Published: May 21, 2019
Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma.
Journal: Scientific reports
Published: May 07, 2019
Last Updated: 09/26/2026